Skip to main content
. 2023 Apr 10;14(2):849–862. doi: 10.21037/jgo-22-858

Table 4. Effectiveness of treatment modalities in new hepatic tumour and new distal metastasis.

Variables HAIC (n=70), n (%) Systemic ICI (n=46), n (%) HAIC and ICI (n=14), n (%) P value
Recurrent of new hepatic tumour, yes (%) 20 (28.57) 8 (17.39) 1 (7.14) 0.130
Recurrent of new distal metastasis, yes (%) 7 (10.00) 11 (23.91) 4 (28.57) 0.069

HAIC, hepatic arterial infusion chemotherapy; ICI, immune checkpoint inhibitor.